Markets are about supporting better light bulbs until they reach critical awareness and adoption mass, in a fickle market, impatience takes a 100m mc company, into a 10m mc, when the reverse can apply into a market that is looking at the expanding revenues, and sees world wide scale..
If a product is superior, offers less infection and complication, a better outcome for patient, it is a better light bulb.
The prize is substantial. Markets may have been dis enchanted in the slow roll out, and delays from regulators, but much of that is behind us now, and knocking on chinas door as well to many countries doors world wide are open for us. The momentum can rebuild, if markets recognize the discounted entry, at 1/10th of where it was in 2019, and potential news events around china, as well growing organic revenues. With down trends, there are only so many sellers who are going to be willing to give away at lows, until the registry is firmed with long holders. At which, supply of low hanging fruit can dry up. And upward price pressure can return.
OSX Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held
